T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
SEACOR Marine Holdings
SMHI
$263M
| $53K | ﹤0.01% |
+10,395
| New | +$64.2K |
|
2902
ADC Therapeutics
ADCT
$131M
| $52K | ﹤0.01% |
36,211
+7,380
| +26% | +$12.5K |
|
|
RGLS
2903
DELISTED
Regulus Therapeutics
RGLS
| $52K | ﹤0.01% |
29,597
| – | – |
|
2904
Tenaya Therapeutics
TNYA
$169M
| $52K | ﹤0.01% |
89,570
-46,664
| -34% | -$46K |
|
|
WGSWW
2905
DELISTED
GeneDx Holdings Warrant
WGSWW
| $52K | ﹤0.01% |
243,780
-7,150
| -3% | -$1.6K |
|
2906
Arq
ARQ
$102M
| $52K | ﹤0.01% |
12,457
+2,127
| +21% | +$12.1K |
|
2907
Alta Equipment Group
ALTG
$243M
| $51K | ﹤0.01% |
10,872
+409
| +4% | +$2.55K |
|
2908
Design Therapeutics
DSGN
$912M
| $51K | ﹤0.01% |
13,069
+618
| +5% | +$2.95K |
|
2909
Editas Medicine
EDIT
$442M
| $51K | ﹤0.01% |
43,777
| – | – |
|
2910
CS Disco
LAW
$283M
| $51K | ﹤0.01% |
12,365
+641
| +5% | +$3.12K |
|
2911
PLAYSTUDIOS Inc
MYPS
$67.3M
| $51K | ﹤0.01% |
39,525
| – | – |
|
|
ONL
2912
Orion Office REIT
ONL
$160M
| $51K | ﹤0.01% |
23,650
+886
| +4% | +$3.09K |
|
2913
BRC Inc
BRCC
$211M
| $50K | ﹤0.01% |
23,207
+974
| +4% | +$2.48K |
|
2914
Perspective Therapeutics
CATX
$363M
| $50K | ﹤0.01% |
23,440
+3,748
| +19% | +$11.2K |
|
|
IGMS
2915
DELISTED
IGM Biosciences
IGMS
| $50K | ﹤0.01% |
42,864
-3,526,135
| -99% | -$6.56M |
|
2916
Nerdy
NRDY
$94.6M
| $48K | ﹤0.01% |
33,611
+3,348
| +11% | +$5.63K |
|
2917
Rackspace Technology
RXT
$1.08B
| $48K | ﹤0.01% |
27,938
+1,131
| +4% | +$2.69K |
|
|
FLNA
2918
Filana Therapeutics
FLNA
$45.3M
| $48K | ﹤0.01% |
31,427
-4,939
| -14% | -$12.5K |
|
2919
Ampco-Pittsburgh
AP
$192M
| $47K | ﹤0.01% |
21,600
| – | – |
|
2920
Clarus
CLAR
$144M
| $46K | ﹤0.01% |
12,069
| – | – |
|
2921
AlTi Global
ALTI
$461M
| $45K | ﹤0.01% |
14,567
+893
| +7% | +$3.2K |
|
2922
Nkarta
NKTX
$170M
| $45K | ﹤0.01% |
23,958
| – | – |
|
2923
Goldgroup Mining Inc.
GORO
$210M
| $44K | ﹤0.01% |
84,700
| – | – |
|
|
MAPS
2924
DELISTED
WM TECHNOLOGY INC A
MAPS
| $44K | ﹤0.01% |
38,765
| – | – |
|
2925
Future Fuel
FF
$254M
| $43K | ﹤0.01% |
10,860
+705
| +7% | +$3.39K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.